Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent nucleic acid endonucleases (CEN) and has inhibitory effects on influenza virus replication. cap-dependent endonuclease-IN-21 has shown research potential against influenza virus infection (influenza A).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | Cap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent nucleic acid endonucleases (CEN) and has inhibitory effects on influenza virus replication. cap-dependent endonuclease-IN-21 has shown research potential against influenza virus infection (influenza A). |
Molecular Weight | 527.47 |
Formula | C26H23F2N3O7 |
CAS No. | 2741952-35-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cap-dependent endonuclease-IN-21 2741952-35-0 inhibitor inhibit